GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma?
Standard
GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma? / Gagelmann, Nico; Brudno, Jennifer.
In: LANCET HAEMATOL, Vol. 10, No. 2, 02.2023, p. e82-e83.Research output: SCORING: Contribution to journal › Comment/debate › Research
Harvard
Gagelmann, N & Brudno, J 2023, 'GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma?', LANCET HAEMATOL, vol. 10, no. 2, pp. e82-e83. https://doi.org/10.1016/S2352-3026(22)00385-4
APA
Gagelmann, N., & Brudno, J. (2023). GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma? LANCET HAEMATOL, 10(2), e82-e83. https://doi.org/10.1016/S2352-3026(22)00385-4
Vancouver
Gagelmann N, Brudno J. GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma? LANCET HAEMATOL. 2023 Feb;10(2):e82-e83. https://doi.org/10.1016/S2352-3026(22)00385-4
Bibtex
@article{19142855399e408884150f00e0ff2413,
title = "GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma?",
keywords = "Humans, Receptors, Chimeric Antigen, Multiple Myeloma/therapy, Immunotherapy, Adoptive, Receptors, G-Protein-Coupled",
author = "Nico Gagelmann and Jennifer Brudno",
year = "2023",
month = feb,
doi = "10.1016/S2352-3026(22)00385-4",
language = "English",
volume = "10",
pages = "e82--e83",
journal = "LANCET HAEMATOL",
issn = "2352-3026",
publisher = "Lancet Publishing Group",
number = "2",
}
RIS
TY - JOUR
T1 - GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma?
AU - Gagelmann, Nico
AU - Brudno, Jennifer
PY - 2023/2
Y1 - 2023/2
KW - Humans
KW - Receptors, Chimeric Antigen
KW - Multiple Myeloma/therapy
KW - Immunotherapy, Adoptive
KW - Receptors, G-Protein-Coupled
U2 - 10.1016/S2352-3026(22)00385-4
DO - 10.1016/S2352-3026(22)00385-4
M3 - Comment/debate
C2 - 36725123
VL - 10
SP - e82-e83
JO - LANCET HAEMATOL
JF - LANCET HAEMATOL
SN - 2352-3026
IS - 2
ER -
